NASDAQ:KTTA | Free Cash Flow | Pasithea Therapeutics Corp.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.79M
2025-12-31-$5.4M
2025-03-31-$3.06M
2024-12-31-$2.44M
2024-03-31-$4.32M
2023-12-31-$3.29M-$36.00-$3.29M
2023-03-31-$3.2M$53,888.00-$3.26M
2022-12-31-$4.42M$92,725.00-$4.51M
2022-03-31-$2.53M$1,951.00-$2.53M
2021-12-31-$1.74M$12,933.00-$1.76M-278.87%
2021-03-31-$381,845.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$15.21M
2024-12-31-$13.92M
2023-12-31-$12.81M$34,301.00-$12.85M
2022-12-31-$14.56M$107,101.00-$14.67M
2021-12-31-$3.17M$21,503.00-$3.2M